Stock listing
Mayne Pharma Group Ltd.
Selected listing: MYX · ASX · AUD · AU
Mayne Pharma Group Ltd. (ASX:MYX), Health Technology. Latest release Sep 30, 2026: MYX settles US patent litigation re Imvexxy with Sun Pharma.
- Ticker
- ASX:MYX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- ASX
- Currency
- AUD
About Mayne Pharma Group Ltd.
The company specializes in the development and commercialization of pharmaceutical products. Mayne Pharma is focused on providing high-quality medicines to improve patient outcomes.
Latest news from Mayne Pharma Group Ltd.
MYX settles US patent litigation re Imvexxy with Sun Pharma
September 29, 2026
2026 Full Year Results Media Release
August 26, 2026
Mayne Pharma reports unaudited Q4 and FY26 results
July 30, 2026
Mayne Pharma receives $14.4m for legal costs from Cosette
June 4, 2026
Court awards MYX $13.27m for legal costs from Cosette
May 21, 2026
Events
Research Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. company profile
View the public company page for Mayne Pharma Group Ltd. on 6ix.
Mayne Pharma Group Ltd. news
Read company news and market updates connected to Mayne Pharma Group Ltd..
Mayne Pharma Group Ltd. investor events
Find investor webinars, events, and replay context for Mayne Pharma Group Ltd..
Alternate listings
MAYNF:OTC
US · USD
Alternate listing for Mayne Pharma Group Ltd.; the primary context on this page is MYX:ASX.
A1C821:LSX
DE · EUR
Alternate listing for Mayne Pharma Group Ltd.; the primary context on this page is MYX:ASX.
HG6:FWB
DE · EUR
Alternate listing for Mayne Pharma Group Ltd.; the primary context on this page is MYX:ASX.
A1C821:LS
DE · EUR
Alternate listing for Mayne Pharma Group Ltd.; the primary context on this page is MYX:ASX.